TR200102107T2 - Tümör nekroz faktör antagonistleri ve endometriozda kullanımları. - Google Patents
Tümör nekroz faktör antagonistleri ve endometriozda kullanımları.Info
- Publication number
- TR200102107T2 TR200102107T2 TR2001/02107T TR200102107T TR200102107T2 TR 200102107 T2 TR200102107 T2 TR 200102107T2 TR 2001/02107 T TR2001/02107 T TR 2001/02107T TR 200102107 T TR200102107 T TR 200102107T TR 200102107 T2 TR200102107 T2 TR 200102107T2
- Authority
- TR
- Turkey
- Prior art keywords
- necrosis factor
- tumor necrosis
- antagonists
- endometriosis
- factor antagonists
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/241—Tumor Necrosis Factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
- A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Tümör nekroz faktör antagonistleri endometriozu tedavi etmek ve/veya önlemek için terapötik olarak etkili dozlarda verilirler. Bu bulusun antagonistleri tipik olarak çesitli sinif moleküller arasindan seçilir fakat tercihen çözünür TNF reseptörleridir. Antagonistler; endometriotik yaralarin iyilesmesi için ve eger baska aktif karisimdaki maddeler ile birlesirse kisirlik gibi alakali rahatsizliklarin iyilesmesi için yararlidirlar.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99101194A EP1022027A1 (en) | 1999-01-22 | 1999-01-22 | Tumor necrosis factor antagonists and their use in endometriosis |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200102107T2 true TR200102107T2 (tr) | 2001-12-21 |
Family
ID=8237393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/02107T TR200102107T2 (tr) | 1999-01-22 | 2000-01-19 | Tümör nekroz faktör antagonistleri ve endometriozda kullanımları. |
Country Status (30)
Country | Link |
---|---|
US (2) | US6663865B1 (tr) |
EP (2) | EP1022027A1 (tr) |
JP (1) | JP4601176B2 (tr) |
KR (2) | KR20060128056A (tr) |
CN (2) | CN1212152C (tr) |
AR (1) | AR022251A1 (tr) |
AT (1) | ATE242002T1 (tr) |
AU (1) | AU771964B2 (tr) |
BG (1) | BG65556B1 (tr) |
BR (1) | BR0008182A (tr) |
CA (1) | CA2356737C (tr) |
CZ (1) | CZ302866B6 (tr) |
DE (1) | DE60003152T2 (tr) |
DK (1) | DK1143997T3 (tr) |
EA (1) | EA003927B1 (tr) |
EE (1) | EE05543B1 (tr) |
ES (1) | ES2200808T3 (tr) |
HK (2) | HK1043059B (tr) |
HU (1) | HU226149B1 (tr) |
IL (2) | IL144413A0 (tr) |
NO (1) | NO328814B1 (tr) |
NZ (1) | NZ512585A (tr) |
PL (1) | PL204713B1 (tr) |
PT (1) | PT1143997E (tr) |
SI (1) | SI1143997T1 (tr) |
SK (1) | SK287313B6 (tr) |
TR (1) | TR200102107T2 (tr) |
UA (1) | UA78483C2 (tr) |
WO (1) | WO2000043031A1 (tr) |
ZA (1) | ZA200105263B (tr) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100857376B1 (ko) * | 2001-01-29 | 2008-09-05 | 라보라토리스 세로노 에스.에이. | 심장 질환의 치료 및/또는 예방에 사용되는 il-18저해물질 |
US20050271663A1 (en) * | 2001-06-28 | 2005-12-08 | Domantis Limited | Compositions and methods for treating inflammatory disorders |
US20060073141A1 (en) * | 2001-06-28 | 2006-04-06 | Domantis Limited | Compositions and methods for treating inflammatory disorders |
EP1709965A3 (en) | 2001-07-11 | 2006-12-27 | Boehringer Ingelheim Pharmaceuticals, Inc. | Methods of treating cytokine mediate diseases |
US7082134B1 (en) * | 2002-01-18 | 2006-07-25 | Juniper Networks, Inc. | Redirect checking in a network device |
US20070298041A1 (en) * | 2002-06-28 | 2007-12-27 | Tomlinson Ian M | Ligands That Enhance Endogenous Compounds |
US9028822B2 (en) | 2002-06-28 | 2015-05-12 | Domantis Limited | Antagonists against TNFR1 and methods of use therefor |
US20060258568A1 (en) * | 2003-02-07 | 2006-11-16 | Austia Wirtschaftsservice Gesellschaft Mit Beschrankter | Use of human chorionic gonadotropin in the treatment in the treatment of symptoms endometriosis |
MXPA06002853A (es) | 2003-09-11 | 2006-06-14 | Kemia Inc | Inhibidores citoquina. |
GB0327112D0 (en) | 2003-11-21 | 2003-12-24 | Clincial Designs Ltd | Dispenser and reservoir |
GB0408449D0 (en) | 2004-04-15 | 2004-05-19 | Banerjee Subhasis | Diagnostic and therapeutic applications of soluble lhcge protein |
JP2008501035A (ja) * | 2004-05-28 | 2008-01-17 | アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ | 妊孕性関連障害の治療におけるil−17の使用 |
US20060045902A1 (en) * | 2004-09-01 | 2006-03-02 | Serbousek Jon C | Polymeric wrap for in vivo delivery of osteoinductive formulations |
EP2446887A3 (en) * | 2005-07-12 | 2012-08-15 | DMI Biosciences, Inc. | Use of danazol for the treatment of Alzheimer's disease |
US8877186B2 (en) * | 2007-06-06 | 2014-11-04 | Domantis Limited | Polypeptides, antibody variable domains and antagonists |
BRPI1010086A2 (pt) * | 2009-06-22 | 2018-02-06 | Dmi Acquisition Corp | método e produtos para tratamento de doenças |
PT2554171E (pt) | 2009-06-22 | 2014-11-06 | Ampio Pharmaceuticals Inc | Método para o tratamento de doenças |
AU2013361338A1 (en) | 2012-12-19 | 2015-08-06 | Ampio Pharmaceuticals, Inc. | Method for treatment of diseases |
CA2978449A1 (en) | 2015-03-02 | 2016-09-09 | 180 Therapeutics Lp | Method of treating a localized fibrotic disorder using an il-33 antagonist |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5037805A (en) * | 1989-03-20 | 1991-08-06 | The Salk Institute For Biological Studies | Methods of contraception |
DE69231828T3 (de) * | 1991-03-18 | 2008-06-19 | New York University | Spezifisch gegen menschlichen Tumornekrosefaktor gerichtete monoklonale und chimäre Antikörper |
US20040120952A1 (en) * | 2000-08-07 | 2004-06-24 | Centocor, Inc | Anti-TNF antibodies and peptides of human tumor necrosis factor |
AU670125B2 (en) * | 1992-09-15 | 1996-07-04 | Immunex Corporation | Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists |
US5389657A (en) * | 1993-02-01 | 1995-02-14 | Free Radical Sciences Corporation | Method for treating infertility |
IL111125A0 (en) * | 1994-05-11 | 1994-12-29 | Yeda Res & Dev | Soluble oligomeric tnf/ngf super family ligand receptors and their use |
US5747532A (en) * | 1995-11-21 | 1998-05-05 | Medinox, Inc. | Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor |
US6090382A (en) * | 1996-02-09 | 2000-07-18 | Basf Aktiengesellschaft | Human antibodies that bind human TNFα |
US5710247A (en) * | 1996-03-19 | 1998-01-20 | Abbott Laboratories | Process and intermediates for the synthesis of LHRH antagonists |
GB9607120D0 (en) * | 1996-04-04 | 1996-06-12 | Chiroscience Ltd | Compounds |
GB9616643D0 (en) * | 1996-08-08 | 1996-09-25 | Chiroscience Ltd | Compounds |
DE69739375D1 (de) * | 1996-11-27 | 2009-06-04 | Immunex Corp | Verfahren zur regulierung der stickstoffmonoxid-erzeugung |
US6514977B1 (en) * | 1997-05-22 | 2003-02-04 | G.D. Searle & Company | Substituted pyrazoles as p38 kinase inhibitors |
-
1999
- 1999-01-22 EP EP99101194A patent/EP1022027A1/en not_active Withdrawn
-
2000
- 2000-01-11 AR ARP000100108A patent/AR022251A1/es unknown
- 2000-01-19 UA UA2001085895A patent/UA78483C2/uk unknown
- 2000-01-19 CA CA2356737A patent/CA2356737C/en not_active Expired - Fee Related
- 2000-01-19 HU HU0105103A patent/HU226149B1/hu not_active IP Right Cessation
- 2000-01-19 DK DK00900306T patent/DK1143997T3/da active
- 2000-01-19 SK SK1029-2001A patent/SK287313B6/sk not_active IP Right Cessation
- 2000-01-19 CN CNB008030308A patent/CN1212152C/zh not_active Expired - Fee Related
- 2000-01-19 EE EEP200100378A patent/EE05543B1/xx not_active IP Right Cessation
- 2000-01-19 KR KR1020067022801A patent/KR20060128056A/ko not_active Application Discontinuation
- 2000-01-19 AT AT00900306T patent/ATE242002T1/de active
- 2000-01-19 BR BR0008182-5A patent/BR0008182A/pt not_active Application Discontinuation
- 2000-01-19 EA EA200100799A patent/EA003927B1/ru not_active IP Right Cessation
- 2000-01-19 NZ NZ512585A patent/NZ512585A/en not_active IP Right Cessation
- 2000-01-19 PT PT00900306T patent/PT1143997E/pt unknown
- 2000-01-19 AU AU19973/00A patent/AU771964B2/en not_active Ceased
- 2000-01-19 JP JP2000594484A patent/JP4601176B2/ja not_active Expired - Fee Related
- 2000-01-19 ES ES00900306T patent/ES2200808T3/es not_active Expired - Lifetime
- 2000-01-19 CN CN200510079556A patent/CN100594932C/zh not_active Expired - Fee Related
- 2000-01-19 EP EP00900306A patent/EP1143997B1/en not_active Expired - Lifetime
- 2000-01-19 IL IL14441300A patent/IL144413A0/xx unknown
- 2000-01-19 CZ CZ20012656A patent/CZ302866B6/cs not_active IP Right Cessation
- 2000-01-19 TR TR2001/02107T patent/TR200102107T2/tr unknown
- 2000-01-19 PL PL350002A patent/PL204713B1/pl unknown
- 2000-01-19 US US09/889,828 patent/US6663865B1/en not_active Expired - Lifetime
- 2000-01-19 SI SI200030168T patent/SI1143997T1/xx unknown
- 2000-01-19 DE DE60003152T patent/DE60003152T2/de not_active Expired - Lifetime
- 2000-01-19 KR KR1020017008575A patent/KR100685106B1/ko not_active IP Right Cessation
- 2000-01-19 WO PCT/IB2000/000052 patent/WO2000043031A1/en active IP Right Grant
-
2001
- 2001-06-26 ZA ZA200105263A patent/ZA200105263B/en unknown
- 2001-07-10 BG BG105691A patent/BG65556B1/bg unknown
- 2001-07-18 IL IL144413A patent/IL144413A/en not_active IP Right Cessation
- 2001-07-19 NO NO20013577A patent/NO328814B1/no not_active IP Right Cessation
-
2002
- 2002-06-28 HK HK02104822.4A patent/HK1043059B/zh not_active IP Right Cessation
-
2003
- 2003-09-22 US US10/666,335 patent/US20040057954A1/en not_active Abandoned
-
2006
- 2006-04-27 HK HK06105041.2A patent/HK1082690A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200102107T2 (tr) | Tümör nekroz faktör antagonistleri ve endometriozda kullanımları. | |
TR199901417T2 (tr) | Analjezik etkisi olan yeni bilesimler. | |
IS4073A (is) | Nýtt fjölvirknislyf gegn aukningu mótstöðu | |
CY1108532T1 (el) | Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων | |
DE60321929D1 (de) | Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen | |
NZ592039A (en) | Combination therapy for the treatment of ocular neovascular disorders | |
TR200000913T2 (tr) | Tıbbi maddeler | |
EA200000911A1 (ru) | Новые кристаллические формы антивирусного соединения бензимидазола | |
CY1105125T1 (el) | Χρηση αναστολεων ακετυλοχολινεστepασης για την παρασκευη φαρμακευτικων συνθεσεων για τη θepαπευτικη αντιμετωπιση συνδρομων λειτουργικων και/ή οργανικων πονων | |
EA200601776A1 (ru) | Метадоновые композиции местного действия и способы их применения | |
ATE371645T1 (de) | Naphthalinderivate, die sich an den ep4?rezeptor binden | |
ATE303804T1 (de) | Behandlung von sexueller funktionsstörung mit bombesin rezeptor antagonisten | |
UA37259C2 (uk) | Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч | |
KR950031106A (ko) | 종양 및 염증성 질환의 선택적 치료를 위한 괴사-유발물질과 괴사에 의해 활성화되는 물질과의 배합물 | |
BR0314797A (pt) | Derivados da pirimidineamida e o uso dos mesmos | |
IS6558A (is) | Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni | |
TR200200066T2 (tr) | Migrenin tedavisi için seçici iGluR5 reseptör antagonistleri | |
TR200200359T2 (tr) | Cgrp Antagonist'lerinin ve cgrp-release (Gevşeme)-Engelleyici Menopoza Bağlı Deri Kızarıklıklarında Kullanılması | |
EA200600817A1 (ru) | Антагонисты в1 рецептора брадикинина (варианты), фармацевтическая композиция, лекарственное средство, способ лечения заболеваний (варианты) | |
TR200103271T2 (tr) | İnflamasyon aracılığıyla gerçekleşen infeksiyon için anti-inflamatuar tedavi. | |
SE9603480L (sv) | Beredningsform för svårlösliga läkemedel | |
TR200102041T2 (tr) | Progesteron reseptör bağlama aktif maddeleri olarak ikameli 2-arilimino heterosaykıllar | |
ATE474572T1 (de) | Heilung von wunden | |
ATE235551T1 (de) | Ligand (tie ligand-4) vom tie-2 rezeptor und dessen verwendungen | |
BRPI0517983A (pt) | uso de corticosteróide em associação com diurético e antiácido para tratamento de estenose vascular e prevenção de reestenose vascular |